Stay updated on Avutometinib Alone vs Combo in Low-Grade Serous Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Avutometinib Alone vs Combo in Low-Grade Serous Ovarian Cancer Clinical Trial page.

Latest updates to the Avutometinib Alone vs Combo in Low-Grade Serous Ovarian Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe page metadata indicates an update to the ClinicalTrials.gov site revision (from v3.5.2 to v3.5.3), with no changes to the underlying study information shown.SummaryDifference0.0%

- Check8 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe Italy location listing was updated from Padua, Italy, 35128 to Padova, Italy, 35128.SummaryDifference0.0%

- Check38 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.0%

- Check45 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3, replacing the previous version. This likely reflects a behind-the-scenes maintenance update.SummaryDifference0.0%

- Check74 days agoChange DetectedThe site update introduces revision 3.4.2 and removes the prior funding-status notices (3.4.1). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Avutometinib Alone vs Combo in Low-Grade Serous Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avutometinib Alone vs Combo in Low-Grade Serous Ovarian Cancer Clinical Trial page.